| Testosterone: The Truth Shall Set The Wimps Free |
| Written by Jose Antonio, PhD | |
| Friday, 18 September 2009 | |
|
Betel Nuts and Testosterone
Arecoline is one of the major components of
betel nuts, which have been consumed as chewing gum in Southeast Asia. In fact,
some folks chew these nuts because of the mild stimulant effect. But there is
something even more intriguing about arecoline, an active component of betel
nuts. And that is its effect on testosterone. In this recent study, the effects
of arecoline on testosterone (T) secretion were studied in male rats that were
injected with human chorionic gonadotropin (hCG, 5 IU/kg) or arecoline (1
microg/kg) plus hCG. They discovered that one intravenous injection of
arecoline resulted in an increase of the hCG-induced level of plasma T. Also,
administration of arecoline in-vitro (i.e., in test tube conditions) increased
T production in Leydig cells (these are the T-producing cells in the
testicles). The stimulatory effect of arecoline on T release in-vitro was
enhanced by hCG and forskolin! Thus, arecoline stimulates testosterone
production by acting directly on the testes.\n This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
</auth-address><titles><title>Effects
of arecoline on testosterone release in
rats</title><secondary-title>Am J Physiol Endocrinol
Metab</secondary-title></titles><periodical><full-title>Am
J Physiol Endocrinol Metab</full-title></periodical><pages>E497-504</pages><volume>295</volume><number>2</number><keywords><keyword>8-Bromo
Cyclic Adenosine Monophosphate/pharmacology</keyword><keyword>Animals</keyword><keyword>Arecoline/*pharmacology</keyword><keyword>Benzylisoquinolines/pharmacology</keyword><keyword>Blotting,
Western</keyword><keyword>Calcium Channels,
L-Type/metabolism</keyword><keyword>Cholinergic
Agonists/*pharmacology</keyword><keyword>Chorionic Gonadotropin/pharmacology</keyword><keyword>Forskolin/pharmacology</keyword><keyword>Leydig
Cells/*drug effects/*metabolism</keyword><keyword>Luteinizing
Hormone/metabolism</keyword><keyword>Male</keyword><keyword>Nifedipine/pharmacology</keyword><keyword>Nimodipine/pharmacology</keyword><keyword>Phosphoproteins/biosynthesis</keyword><keyword>Pituitary
Gland, Anterior/drug
effects/metabolism</keyword><keyword>Rats</keyword><keyword>Rats,
Sprague-Dawley</keyword><keyword>Testosterone/*blood</keyword></keywords><dates><year>2008</year><pub-dates><date>Aug</date></pub-dates></dates><accession-num>18559981</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18559981
</url></related-urls></urls></record></Cite></EndNote>1 Maybe you should go buy some betel
nuts and chew on ‘em. This might be an additional way to get a rise in T.
Dose-Dependent Increases
This was a testosterone
dose-response study in young and older men who received long-acting GnRH
agonist monthly (to turn off normal production of testosterone), plus one of
five-weekly doses of testosterone enanthate (25, 50, 125, 300, or 600mg
intramuscularly) for 20 weeks. Both hemoglobin and hematocrit increased
significantly in a linear, dose-dependent fashion in both young and older men
in response to graded doses of testosterone. But get this; the increases in
hemoglobin and hematocrit were significantly greater in older than young men.\n This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
</auth-address><titles><title>Effects
of graded doses of testosterone on erythropoiesis in healthy young and older
men</title><secondary-title>J Clin Endocrinol
Metab</secondary-title></titles><periodical><full-title>J
Clin Endocrinol Metab</full-title></periodical><pages>914-9</pages><volume>93</volume><number>3</number><keywords><keyword>Adolescent</keyword><keyword>Adult</keyword><keyword>Age
Factors</keyword><keyword>Aged</keyword><keyword>Dose-Response
Relationship, Drug</keyword><keyword>Erythropoiesis/*drug
effects</keyword><keyword>Erythropoietin/blood</keyword><keyword>Hematocrit</keyword><keyword>Hemoglobins/analysis</keyword><keyword>Humans</keyword><keyword>Male</keyword><keyword>Middle
Aged</keyword><keyword>Receptors,
Transferrin/analysis</keyword><keyword>Testosterone/*pharmacology</keyword></keywords><dates><year>2008</year><pub-dates><date>Mar</date></pub-dates></dates><accession-num>18160461</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18160461
</url></related-urls></urls></record></Cite></EndNote>2 From this, it may be better for
older men to be administered testosterone because of the improved blood cell
count. But in addition to EPO, we know why endurance cyclists love their
androgens.
Testosterone Ointment and Patches
Not to be confused with Vick’s VapoRub,
this study looked at the serum total testosterone (TT) and free testosterone
(FT) levels after application of a testosterone ointment (Glowmin, Daito Pharmaceutical
Co. Ltd., Tokyo, Japan) and its clinical efficacy. Accordingly, Glowmin, is a
short-acting testosterone ointment eliciting physiological elevation of both
total and free testosterone!\n This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
</auth-address><titles><title>Profile
of serum testosterone levels after application of testosterone ointment
(glowmin) and its clinical efficacy in late-onset hypogonadism patients</title><secondary-title>J
Sex
Med</secondary-title></titles><periodical><full-title>J
Sex
Med</full-title></periodical><pages>1727-36</pages><volume>5</volume><number>7</number><dates><year>2008</year><pub-dates><date>Jul</date></pub-dates></dates><accession-num>18093097</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18093097
</url></related-urls></urls></record></Cite></EndNote>3 This sounds better than rubbing KY
Jelly. I can see the commercials now. Glowmin. Rub it on now, and rub it on it
later. And in a similar study, 60 men were given transdermal testosterone
patches or placebo for 52 weeks. Testosterone therapy, relative to placebo,
selectively lessened visceral fat accumulation without change in total body fat
mass and increased total body fat-free mass or lean body mass and total body
and thigh skeletal muscle mass.4 So here’s an example where giving T
can actually lessen cardiovascular disease risk by a drop in visceral fat. And
to top it off, you can get lean body mass as well!
No Sissies Allowed
Guys with more testosterone are the
alpha-males, correct? In this interesting psycho/biological study, scientists
suggested a link between social anxiety and social dominance. Scientists thus
tested the ideal socially anxious individuals (i.e., Woody Allen, Michael
Moore, etc.) who would respond to a social-dominance threat by exhibiting
decrements in their testosterone levels. A drop in T is an endocrinological
change that typically reflects pronounced social submission in humans and other
animals. In this study, participants were randomly assigned to either win or
lose a rigged face-to-face competition with a confederate. Although no
zero-order relationship between social anxiety and level of testosterone was
observed, testosterone levels showed a pronounced drop among socially anxious
men who lost the competition. What a bunch a wimps! No significant changes were
observed in non-anxious men or in women. According to the investigators, “This
research provides novel insight into the nature and consequences of social
anxiety and also illustrates the utility of integrating social psychological
theory with endocrinological approaches to psychological science.”\n This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
</auth-address><titles><title>Submitting to
defeat: social anxiety, dominance threat, and decrements in testosterone</title><secondary-title>Psychol
Sci</secondary-title></titles><periodical><full-title>Psychol
Sci</full-title></periodical><pages>764-8</pages><volume>19</volume><number>8</number><dates><year>2008</year><pub-dates><date>Aug</date></pub-dates></dates><accession-num>18816282</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18816282
</url></related-urls></urls></record></Cite></EndNote>5 Or in other words, don’t hang
around those who are exhibiting high anxiety, because they are high on the wimp
scale.
In another psycho/biological study,
men with more a masculine facial structures show higher levels of circulating
testosterone than men with less masculine faces. Thus, we have scientific proof
that shows that a man's facial structure may afford important information about
the functioning of his endocrine system.6 Perhaps that explains the
differences in masculinity between Arnold, the Governor of California, and
Barney Frank.
High TE For Better Results
We of course know that higher
testosterone levels confer social dominance, a more masculine face and better
results on the bench press. So why the negative spin that so permeates the
mainstream press on testosterone? One would think that testosterone were like
cyanide. Don’t touch the stuff, ‘cause it’ll kill you! Of course, we know most
journalists have the IQ somewhere between a betel nut and skunk. Despite the
growing body of evidence that testosterone, when used properly, can confer
beneficial effects, the fix is in. The mainstream press, will not in our
lifetime, ever admit to such. Heck, who cares about the facts when it gets in
the way of your conclusions. Even older men who are administered testosterone
show improvements in various parameters. In what might call a fairly long-term
study (as far as androgens go), monthly treatment with a gonadotropin-releasing
hormone agonist plus 25, 50, 125, or 300mg/week of intramuscular injections of
testosterone enanthate for 20 weeks was analyzed. Did anything bad happen? I
mean come on. Someone must have died, right? Inquiring minds want to know.
Here’s what they found; there was a significant testosterone dose- and
concentration-dependent increase in skeletal muscle mass, as well as maximal
strength. Leg power also increased dose-dependently. So what we have here is
proof that testosterone administration increases strength and muscle mass even
in older men.7 No deaths, no crazy side effects.
Go figure. The truth shall set you free!
References:
1. Wang
SW, Hwang GS, Chen TJ, Wang PS. Effects of arecoline on testosterone release in
rats. Am J Physiol Endocrinol Metab, Aug 2008;295(2):E497-504.
2. Coviello
AD, Kaplan B, Lakshman KM, Chen T, Singh AB, Bhasin S. Effects of graded doses
of testosterone on erythropoiesis in healthy young and older men. J Clin
Endocrinol Metab,
Mar 2008;93(3):914-919.
3. Amano
T, Imao T, Takemae K, et al. Profile of serum testosterone levels after
application of testosterone ointment (glowmin) and its clinical efficacy in
late-onset hypogonadism patients. J Sex Med, Jul 2008;5(7):1727-1736.
4. Allan
CA, Strauss BJ, Burger HG, Forbes EA, McLachlan RI. Testosterone therapy
prevents gain in visceral adipose tissue and loss of skeletal muscle in
nonobese aging men. J Clin Endocrinol Metab, Jan 2008;93(1):139-146.
5. Maner
JK, Miller SL, Schmidt NB, Eckel LA. Submitting to defeat: social anxiety,
dominance threat, and decrements in testosterone. Psychol Sci, Aug 2008;19(8):764-768.
6. Pound
N, Penton-Voak IS, Surridge AK. Testosterone responses to competition in men
are related to facial masculinity. Proc Biol Sci, Sep 16 2008.
7. Storer
TW, Woodhouse L, Magliano L, et al. Changes in Muscle Mass, Muscle Strength,
and Power but Not Physical Function Are Related to Testosterone Dose in Healthy
Older Men. J Am Geriatr Soc, Sep 15 2008.
|